Remarks on the genus Emeljanovianus Dlabola, 1965 (Hemiptera: Auchenorrhyncha: Cicadellidae), with description of a new species from Italy.

Emeljanvianus hyperprocessatus sp. n. from Italy is described and illustrated.

Patient mortality after total hip arthroplasty revision surgery.

Background: Complications following revision total hip arthroplasty can cause significant morbidity and have a high mortality rate. Patient age and American Society of Anaesthesiologists (ASA) physical status classification system score are important determinants of mortality following revision hip arthroplasty. There is a paucity of high-quality evidence assessing the risk of mortality following revision hip arthroplasty stratified by indications of surgery.

Description of the immature and mature larvae of Bocchus scobiolae Nagy (Hymenoptera: Dryinidae).

The last immature instar and the mature larva of Bocchus scobiolae are described and illustrated for the first time. The affinities of both immature and mature larvae of Bocchus scobiolae and Mystrophorus formicaeformis are discussed to define larval characters of the subfamily Bocchinae.

Study on the genus Dudanus (Auchenorrhyncha, Cicadellidae, Deltocephalinae) in Western and Central Europe with description of a new species.

Adults and last juvenile stage of a new Dudanus species, Dudanus karra n. sp., are described and illustrated.

Differences in white matter microstructure in first-episode schizophrenia spectrum disorders vs healthy volunteers and their association with cognition.

Objective: Both cognitive impairment and alterations in white matter tissue microstructure are well recognised in schizophrenia. We investigated whether differences in white matter microstructure underpin cognitive impairments in patients with first-episode schizophrenia spectrum disorders when controlling for multiple confounding factors.

Methods: We employed a cross-sectional study design and compared fractional anisotropy (FA) between individuals diagnosed with first- episode schizophrenia spectrum disorders (FES) (n = 68) and matched healthy controls (n = 120).